Antithrombotic efficacy of low-molecular-weight heparin in deep arterial injury.
- 1 February 1992
- journal article
- abstracts
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 12 (2) , 250-255
- https://doi.org/10.1161/01.atv.12.2.250
Abstract
Low-molecular-weight heparin subfractions more specifically inhibit factor Xa than thrombin, and they may have advantages over unfractionated heparin in arterial thrombosis. The antithrombotic efficacy of four dosages of a low-molecular-weight heparin (CY216 at 100, 200, 400, or 500 Institute Choay units/kg) was compared with unfractionated calcium heparin (100 US Pharmacopeia units/kg) and placebo during deep arterial injury produced by balloon dilatation of the carotid artery in the pig. The acute thrombotic end points were 111In-labeled platelet and 125I-labeled fibrinogen/fibrin deposition and macroscopic mural thrombosis; these were related to the anti-factor Xa and antithrombin effects of the heparin preparations. Platelet deposition in segments with deep arterial injury was 42 +/- 28, 22 +/- 5, 29 +/- 12, 9 +/- 2, 9 +/- 2, and 11 +/- 3 x 10(6)/cm2 (mean +/- SEM) for pigs treated with placebo, with 100, 200, 400, and 500 units/kg CY216, and with 100 units/kg unfractionated heparin, respectively. Fibrinogen/fibrin deposition was 35 +/- 8, 19 +/- 2, 19 +/- 4, 21 +/- 3, 14 +/- 4, and 12 +/- 3 molecules x 10(12)/cm2, respectively; deposition was significantly reduced in pigs given 100 units/kg unfractionated heparin compared with placebo (p less than 0.05). Mural thrombosis was present in 74%, 45%, 30%, 14%, 5%, and 9% of deeply injured arterial segments, respectively (p = 0.02). Plasma anti-factor Xa activity and prolongation of the activated partial thromboplastin time (aPTT) with 100 units/kg unfractionated heparin were similar to that produced by 200 units/kg and 500 units/kg CY216, respectively. Thus, low-molecular-weight heparin, which predominantly inhibits factor Xa activity, was only moderately effective at reducing platelet thrombus deposition. It was less effective than 100 units/kg unfractionated heparin, except at high dosages, producing similar prolongation of the aPTT and the thrombin time.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 17 references indexed in Scilit:
- Tick Anticoagulant Peptide (TAP) Is a Novel Inhibitor of Blood Coagulation Factor XaScience, 1990
- Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and fragminThrombosis Research, 1990
- Pharmacology and special clinical applications of low‐molecular‐weight heparinsAmerican Journal of Hematology, 1988
- Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractionsThrombosis Research, 1986
- Low-Molecular-Weight HeparinNew England Journal of Medicine, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphateBritish Journal of Haematology, 1985
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.Journal of Clinical Investigation, 1983
- Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.BMJ, 1982
- Effect of Heparin and Heparin Fractions on Platelet AggregationJournal of Clinical Investigation, 1980